Tetrabenazine-d6

CAS No.	1392826-25-3	Cat. No.	BCP16001
Name	Tetrabenazine-d6
Synonyms	SD809; SD-809; SD 809; Deutetrabenazine;Ro 1-9569 D6; GTPL8707;Tetrabenazine D6;
Formula	C19H27NO3	M. Wt	317.42

Description	Tetrabenazine-d6, also known as SD-809 and Deutetrabenazine, is an investigational, oral, small-molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD-809 is being developed for the treatment of chorea associated with Huntington’s disease, a neurodegenerative movement disorder that impacts cognition, behavior, and movements. Teva is investigating the broad potential of SD-809 for treating additional movements disorders such as tardive dyskinesia and tics associated with Tourette syndrome.
Pathways	Ion Channel/Membrane Transporter
Targets	Monoamine Transporter

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.